Literature DB >> 15201609

Osteonecrosis: etiology, diagnosis, and treatment.

Lynne C Jones1, David S Hungerford.   

Abstract

PURPOSE OF REVIEW: This review provides an update of the recent progress in etiology, pathogenesis, diagnosis, and treatment of osteonecrosis. RECENT
FINDINGS: Concerning pathogenesis, there is evidence that there is a genetic predilection for those who are exposed to the two leading etiologic associations for osteonecrosis: corticosteroids and alcohol. Studies concerning the treatment of osteonecrosis indicate that most preservative (ie, joint-sparing) procedures available today have better results in the precollapse stages of the disease and in smaller lesions. Therefore, researchers continue to develop and modify diagnostic techniques, particularly relating to MRI, for the identification and quantification of osteonecrotic lesions. Advances concerning bone grafting and arthroplasty procedures have resulted in improved clinical outcomes for this patient population. The future treatment of osteonecrosis may involve genetic or cell-based therapies.
SUMMARY: Although progress has been made, considerably more research is needed before we fully understand this disease. Hopefully, such research will lead to effective measures for saving the femoral head or, better yet, preventing osteonecrosis.

Entities:  

Mesh:

Year:  2004        PMID: 15201609     DOI: 10.1097/01.moo.0000127829.34643.fd

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  29 in total

1.  CORR® ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor-γ (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation.

Authors:  Cody C Wyles; Christopher R Paradise; Matthew T Houdek; Susan L Slager; Andre Terzic; Atta Behfar; Andre J van Wijnen; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2019-08       Impact factor: 4.176

2.  Establishing Classification Tree Models in Rheumatoid Arthritis Using Combination of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry and Magnetic Beads.

Authors:  Dan Ma; Nana Liang; Liyun Zhang
Journal:  Front Med (Lausanne)       Date:  2021-02-24

3.  11β-hydroxysteroid dehydrogenases as targets in the treatment of steroid-associated femoral head necrosis using antler extract.

Authors:  Ribusurong Pu; Hao Peng
Journal:  Exp Ther Med       Date:  2017-11-07       Impact factor: 2.447

4.  Blood supply to the chicken femoral head.

Authors:  Jianzhong Xu; Xiuli Wang; C Brian Toney; Jesse Seamon; Quanjun Cui
Journal:  Comp Med       Date:  2010-08       Impact factor: 0.982

Review 5.  Potential pathophysiological mechanisms in osteonecrosis of the jaw.

Authors:  Regina Landesberg; Victoria Woo; Serge Cremers; Matthew Cozin; Darja Marolt; Gordana Vunjak-Novakovic; Stavroula Kousteni; Srikala Raghavan
Journal:  Ann N Y Acad Sci       Date:  2011-02       Impact factor: 5.691

6.  Value of whole-body magnetic resonance imaging for screening multifocal osteonecrosis in patients with polymyositis/dermatomyositis.

Authors:  Huang Zhen-Guo; Yang Min-Xing; Chen Xiao-Liang; Yan Ran; Chen He; Gao Bao-Xiang; Yin Li-Guo; Shi Kai-Ning; Queenie Chan; Wang Guo-Chun
Journal:  Br J Radiol       Date:  2017-03-29       Impact factor: 3.039

7.  Osteonecrosis of the femoral head: using CT, MRI and gross specimen to characterize the location, shape and size of the lesion.

Authors:  L B Hu; Z G Huang; H Y Wei; W Wang; A Ren; Y Y Xu
Journal:  Br J Radiol       Date:  2014-12-11       Impact factor: 3.039

Review 8.  [Transient osteoporosis and osteonecrosis of the femoral head. Risk factors, classification and differential diagnosis].

Authors:  C P Rader
Journal:  Orthopade       Date:  2007-05       Impact factor: 1.087

9.  Osteonecrosis of the femoral head in patients with type 1 human immunodeficiency virus infection: clinical analysis and review.

Authors:  Jean-Cyr Yombi; Bernard Vandercam; Dunja Wilmes; Jean-Emile Dubuc; Anne Vincent; Pierre-Louis Docquier
Journal:  Clin Rheumatol       Date:  2009-03-10       Impact factor: 2.980

Review 10.  Chemotherapy-associated osteonecrosis in cancer patients with solid tumours: a systematic review.

Authors:  Katharine Shim; Mary J MacKenzie; Eric Winquist
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.